Fraunhofer Institute for Computer Graphics Research IGD
RenalCare: AI-based surgical planning and risk assessment for kidney tumour resection
Where medically possible, partial resections, also known as partial nephrectomies, are preferred for kidney tumours. The aim is to preserve as much healthy kidney tissue as possible while minimising perioperative and postoperative risks. Until now, medical teams have based their decision on whether a patient is eligible for kidney-preserving partial resection on 2D image data of the tumour findings.
In the BMBF-funded RenalCare project, Fraunhofer IGD is working with clinical and industrial partners to develop software solutions that convert 2D image data into 3D data, supporting patient-specific surgical planning and clinical decision-making.
Are you interested in collaborating with us or do you have questions about specific use cases? Our expert Dr.-Ing. Cristina Oyarzun Laura will be happy to assist you.
Risk assessment for kidney tumours: why nephrometry scores matter
Nephrometry scores play an important role in treatment decisions. They help medical teams assess kidney tumours based on more than just their size. Instead, they take into account various parameters that are relevant for evaluating risks and potential complications.
These scores can help more patients benefit from partial nephrectomy. At the same time, they support clinical assessment of which treatment option is suitable in each individual case.
Despite their advantages, these scores are often not used in daily clinical routine. One reason for this is the increasing complexity involved in calculating them.
Automated assessment of relevant scores
RenalCare automatically calculates relevant scores such as Padua, R.E.N.A.L., C and ABC for the planning of kidney tumour treatment. The calculation is based on image and text analysis. Relevant information is extracted, visualised, integrated into a structured report and made available to medical teams.
The tool combines automated analysis methods with clear and intuitive visualisations. Complex information on kidney tumours is presented in a structured and accessible way. The software solution makes relevant data available more quickly for treatment planning and supports medical teams in making data-based clinical decisions.
Please contact us to learn more about RenalCare or potential collaboration opportunities.
RenalViz: gaining a better understanding of chronic kidney disease
RenalViz enables patient cohorts to be visually compared, patterns in disease progression to be identified and clinical decisions to be supported with data-based insights.
RenalCare – AI-based surgical planning and risk assessment for kidney tumours
Privacy warning
With the click on the play button an external video from www.youtube.com is loaded and started. Your data is possible transferred and stored to third party. Do not start the video if you disagree. Find more about the youtube privacy statement under the following link: https://policies.google.com/privacyRenalCare – AI-based surgical planning and risk assessment for kidney tumours
What is RenalCare?
RenalCare is a BMBF-funded project in which Fraunhofer IGD works with clinical and industrial partners to develop software solutions that support patient-specific clinical decision-making for kidney tumours.
How does RenalCare support medical teams in the resection of kidney tumours?
RenalCare supports medical teams in the resection of kidney tumours by automatically analysing relevant information from image and text data and bringing it together in a structured report. The tool calculates important nephrometry scores such as Padua, R.E.N.A.L., C and ABC, helping to better assess risks and potential complications. This enables treatment planning to be prepared in a patient-specific and data-based way.
Which scores does RenalCare calculate automatically?
RenalCare automatically calculates relevant nephrometry scores. These include Padua, R.E.N.A.L., C and ABC.
Why are nephrometry scores important for kidney tumours?
Nephrometry scores support treatment decisions because they take into account more than just tumour size. They include various parameters that can help assess risks and potential complications.
How can RenalCare support surgical planning and risk assessment for kidney tumours?
RenalCare supports treatment planning for kidney tumours through automated image and text analysis. Relevant information is extracted, visualised and integrated into a structured report.
How can I contact RenalCare about potential collaboration?
For further information or collaboration enquiries, our expert Dr.-Ing. Cristina Oyarzun Laura will be happy to assist you.